NasdaqGM - BOATS Real Time Price USD

Quantum-Si incorporated (QSI)

1.4300 +0.3600 (+33.64%)
At close: 1 October at 16:00:00 GMT-4
1.4000 -0.0300 (-2.10%)
Overnight: 1:25:49 GMT-4
Chart Range Bar
Loading chart for QSI
Chart does not reflect overnight price.
  • Previous close 1.0700
  • Open 1.2000
  • Bid 0.5415 x 200
  • Ask 0.9885 x 200
  • Day's range 1.1500 - 1.4800
  • 52-week range 0.6900 - 3.1000
  • Volume 32,524,337
  • Avg. Volume 3,441,841
  • Market cap (intra-day) 313.004M
  • Beta (5Y monthly) 3.25
  • PE ratio (TTM) --
  • EPS (TTM) -0.6100
  • Earnings date (est.) 5 Nov 2026
  • Forward dividend & yield --
  • Ex-dividend date --
  • 1y target est 2.28

Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.

www.quantum-si.com

145

Full-time employees

31 December

Fiscal year ends

Healthcare

Sector

Medical Devices

Industry

Performance overview

Trailing total returns as of 01/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD return

QSI
30.00%
S&P 500 (^GSPC)
11.99%

1-year return

QSI
2.05%
S&P 500 (^GSPC)
14.23%

3-year return

QSI
13.86%
S&P 500 (^GSPC)
78.79%

5-year return

QSI
83.04%
S&P 500 (^GSPC)
75.96%

Earnings trends

View more

Earnings per share

GAAP
Normalised
GAAP
Normalised
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 344k
Earnings -23.53M
Profit margin -6,841.28%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-30m
-20m
-10m
0
-8000.0%
-7000.0%
-6000.0%
-5000.0%
-4000.0%
 

Analyst insights

View more

Analysts' price targets

1.00
2.28 Average
1.4300 Current
3.95 High
 

Analyst recommendations

  • Strong buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest rating

Date 29/09/2026
Analyst HC Wainwright & Co.
Rating action Reiterates
Rating Buy
Price action Maintains
Price target 4 -> 4
 

Statistics

View more

Valuation measures

As of 23/09/2026
  • Market cap

    166.33M

  • Enterprise value

    57.84M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG ratio (5-yr expected)

    --

  • Price/sales (ttm)

    101.72

  • Price/book (mrq)

    0.92

  • Enterprise value/revenue

    36.04

  • Enterprise value/EBITDA

    --

Financial highlights

Profitability and income statement

  • Profit margin

    0.00%

  • Return on assets (ttm)

    -25.71%

  • Return on equity (ttm)

    -49.11%

  • Revenue (ttm)

    1.6M

  • Net income avi to common (ttm)

    -98.52M

  • Diluted EPS (ttm)

    -0.6100

Balance sheet and cash flow

  • Total cash (mrq)

    111.74M

  • Total debt/equity (mrq)

    1.81%

  • Levered free cash flow (ttm)

    -50.13M

Compare

Select to analyse similar companies using key performance metrics; select up to four stocks.

People also watch